Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

National Notifiable Infectious Diseases and Conditions: United States

TABLE 6. Reported cases of notifiable diseases and rates per 100,000, by race, excluding U.S. territories - - United States, 2016
Disease American Indian or
Alaska Native
Asian or Pacific
Islander
Black White Other Race Race not stated Suppressed * Total
No. Rate No. Rate No. Rate No. Rate No. No. No. No.
Anthrax
Arboviral diseases
Chikungunya virus disease 65 0.32 14 0.03 79 0.03 18 71 247
Eastern equine encephalitis virus disease
Neuroinvasive S S S S S S S S S S 7 7
Non-neuroinvasive
Jamestown Canyon virus disease
Neuroinvasive S S S S S S S S S S 7 7
Non-neuroinvasive S S S S S S S S S S 8 8
La Crosse virus disease
Neuroinvasive 25 0.01 6 31
Non-neuroinvasive S S S S S S S S S S 4 4
Powassan virus disease
Neuroinvasive S S S S S S S S S S 21 21
Non-neuroinvasive S S S S S S S S S S 1 1
St. Louis encephalitis virus disease
Neuroinvasive S S S S S S S S S S 7 7
Non-neuroinvasive S S S S S S S S S S 1 1
West Nile virus disease
Neuroinvasive 11 0.24 12 0.06 63 0.14 920 0.36 35 267 1,308
Non-neuroinvasive 5 0.11 6 0.03 21 0.05 600 0.24 11 198 841
Western equine encephalitis virus disease
Neuroinvasive
Non-neuroinvasive
Babesiosis
Total 7 0.26 44 0.28 41 0.14 1,150 0.63 19 649 1,910
Confirmed 4 0.15 44 0.28 36 0.12 947 0.52 16 538 1,585
Probable 3 0.11 5 0.02 203 0.11 3 111 325
Botulism
Total 5 0.11 9 0.04 19 0.04 123 0.05 3 42 201
Foodborne 3 0.06 2 0.01 12 0.03 9 0.00 5 31
Infant 1 1.29 7 2.80 5 0.73 96 3.24 3 32 144
Other (wound & unspecified) 1 0.02 2 0.00 18 0.01 5 26
Brucellosis 2 0.04 4 0.02 3 0.01 85 0.03 15 18 127
Campylobacteriosis 479 10.35 1,582 7.72 2,721 6.01 36,747 14.54 3,189 15,402 60,120
Chancroid † S S S S S S S S S S 7 7
Chlamydia trachomatis infection † 18,735 404.63 25,594 124.92 452,165 998.00 519,401 205.54 80,410 502,049 1,598,354
Cholera S S S S S S S S S S 15 15
Coccidioidomycosis § 167 7.03 332 3.45 431 3.02 3,659 3.49 542 6,698 11,829
Cryptosporidiosis
Total 106 2.29 154 0.75 1,283 2.83 9,052 3.58 471 2,387 13,453
Confirmed 75 1.62 101 0.49 864 1.91 5,663 2.24 306 1,628 8,637
Probable 31 0.67 53 0.26 419 0.92 3,389 1.34 165 759 4,816
Cyclosporiasis 1 0.03 14 0.07 14 0.03 370 0.16 28 110 537
Dengue virus infections ¶
Dengue 1 0.02 161 0.79 60 0.13 396 0.16 57 228 903
Dengue-like illness 6 0.03 2 0.00 13 0.01 8 11 40
Severe dengue S S S S S S S S S S 10 10
Diphtheria
Ehrlichiosis and Anaplasmosis
Anaplasma phagocytophilum infection 35 0.85 29 0.15 17 0.04 2,686 1.10 36 1,348 4,151
Ehrlichia chaffeensis infection 8 0.19 4 0.02 24 0.05 963 0.40 18 360 1,377
Ehrlichia ewingii infection S S S S S S S S S S 22 22
Undetermined ehrlichiosis/anaplasmosis 2 0.05 2 0.01 1 0.00 131 0.05 7 57 200
Giardiasis 93 2.60 430 2.45 1,333 3.89 8,049 4.06 728 5,677 16,310
Gonorrhea † 6,059 130.86 6,208 30.30 192,977 425.93 144,335 57.12 20,565 98,370 468,514
Haemophilus influenzae, invasive disease
All ages, all serotypes 62 1.34 75 0.37 671 1.48 3,183 1.26 144 760 4,895
Age <5 years
Serotype b 5 1.30 1 0.03 19 0.13 1 4 30
Non-b serotype 15 3.89 3 0.23 38 1.11 79 0.53 3 21 159
Nontypeable 4 1.04 4 0.31 36 1.06 111 0.75 9 32 196
Unknown serotype 7 1.81 9 0.70 31 0.91 96 0.65 15 29 187
Hansen's disease 12 0.06 5 0.01 36 0.02 1 24 78
Hantavirus infection, non-hantavirus pulmonary syndrome S S S S S S S S S S 6 6
Hantavirus pulmonary syndrome 8 0.18 19 0.01 1 3 31
Hemolytic uremic syndrome post-diarrheal 2 0.04 7 0.04 7 0.02 239 0.10 21 31 307
Hepatitis **
A, acute 3 0.06 301 1.47 141 0.31 1,073 0.42 142 347 2,007
B, acute 15 0.33 56 0.27 389 0.87 2,187 0.87 131 440 3,218
B, perinatal infection 18 3.54 4 0.29 1 0.02 1 8 32
C, acute 71 1.77 25 0.13 135 0.31 2,221 0.93 82 408 2,942
Human immunodeficiency virus diagnoses 219 4.73 801 3.91 15,632 34.50 9,398 3.72 8,725 34,775
Influenza-associated pediatric mortality 1 0.07 6 0.13 9 0.07 55 0.10 1 10 82
Invasive pneumococcal disease
All ages 309 10.75 218 1.84 2,821 7.58 10,403 5.51 457 3,418 17,626
Confirmed 308 10.71 218 1.84 2,817 7.57 10,388 5.50 457 3,415 17,603
Probable S S S S S S S S S S 23 23
Age <5 years 18 0.53 41 0.32 223 0.56 591 0.29 42 227 1,142
Confirmed 17 5.85 41 4.93 222 7.42 589 4.98 42 226 1,137
Probable S S S S S S S S S S 5 5
Legionellosis 26 0.56 99 0.48 1,068 2.36 3,891 1.54 242 815 6,141
Leptospirosis 8 0.05 1 0.00 38 0.02 13 18 78
Listeriosis 9 0.19 70 0.34 68 0.15 533 0.21 20 86 786
Lyme disease
Total 81 1.75 303 1.55 298 0.66 18,841 7.47 990 15,916 36,429
Confirmed 57 1.23 210 1.07 205 0.45 13,381 5.30 776 11,574 26,203
Probable 24 0.52 93 0.48 93 0.21 5,460 2.16 214 4,342 10,226
Malaria 6 0.13 91 0.44 1,052 2.32 248 0.10 67 491 1,955
Measles
Total 8 0.04 5 0.01 37 0.01 1 34 85
Indigenous 2 0.01 2 0.00 32 0.01 32 68
Imported S S S S S S S S S S 17 17
Meningococcal disease
All serogroups 9 0.19 12 0.06 60 0.13 229 0.09 15 50 375
Serogroups ACWY 7 0.15 4 0.02 22 0.05 70 0.03 6 17 126
Serogroup B 1 0.02 1 0.00 15 0.03 58 0.02 2 9 86
Other serogroups S S S S S S S S S S 21 21
Unknown serogroup 1 0.02 6 0.03 19 0.04 90 0.04 6 20 142
Mumps 20 0.43 2,140 10.45 220 0.49 2,980 1.18 135 874 6,369
Novel Influenza A virus infections S S S S S S S S S S 23 23
Pertussis 123 2.66 312 1.52 775 1.71 11,694 4.63 649 4,419 17,972
Plague S S S S S S S S S S 4 4
Poliomyelitis, paralytic
Poliovirus infection, nonparalytic
Psittacosis S S S S S S S S S S 12 12
Q fever
Total 1 0.02 3 0.01 7 0.02 99 0.04 10 44 164
Acute 1 0.02 2 0.01 6 0.01 83 0.03 8 32 132
Chronic 1 0.00 1 0.00 16 0.01 2 12 32
Rabies
Human
Rubella S S S S S S S S S S 1 1
Rubella, congenital syndrome S S S S S S S S S S 2 2
Salmonellosis 532 11.49 1,671 8.16 4,401 9.71 34,546 13.67 2,456 10,244 53,850
Severe acute respiratory syndrome-associated coronavirus disease
Shiga toxin-producing Escherichia coli †† 58 1.25 174 0.85 341 0.75 5,563 2.20 361 1,672 8,169
Shigellosis 320 6.91 328 1.60 3,982 8.79 11,547 4.57 1,039 3,881 21,097
Smallpox
Spotted fever rickettsiosis
Total 42 0.93 16 0.08 112 0.25 2,927 1.16 62 1,110 4,269
Confirmed 3 0.07 8 0.02 98 0.04 4 41 154
Probable 39 0.87 16 0.08 104 0.23 2,829 1.12 58 1,069 4,115
Streptococcal toxic shock syndrome 1 0.04 6 0.06 43 0.14 194 0.12 14 25 283
Syphilis
Total, all stages †,§§ 613 13.24 2,353 11.49 30,820 68.02 41,719 16.51 6,062 6,475 88,042
Congenital 12 15.49 26 10.39 261 38.32 281 9.49 14 34 628
Primary and secondary † 219 4.73 768 3.75 9,341 20.62 14,103 5.58 1,673 1,710 27,814
Tetanus 1 0.00 3 0.01 21 0.01 2 7 34
Toxic shock syndrome (other than Streptococcal) 1 0.01 1 0.00 25 0.01 2 11 40
Trichinellosis 5 0.11 8 0.04 2 0.00 8 0.00 3 26
Tuberculosis 127 2.74 3,212 15.68 2,026 4.47 3,676 1.45 132 99 9,272
Tularemia 23 0.50 5 0.01 152 0.06 7 43 230
Typhoid fever 4 0.09 185 0.90 31 0.07 61 0.02 29 66 376
Vancomycin-intermediate Staphylococcus aureus 1 0.03 2 0.02 23 0.06 61 0.03 6 15 108
Vancomycin-resistant Staphylococcus aureus
Varicella morbidity 84 2.40 404 2.31 556 1.51 5,583 2.77 375 1,951 8,953
Varicella mortality U U U U U U U U U U U U
Vibriosis
Total 9 0.20 45 0.22 76 0.17 856 0.34 36 251 1,273
Confirmed 9 0.20 42 0.21 71 0.16 837 0.34 36 246 1,241
Probable 3 0.01 5 0.01 19 0.01 5 32
Viral hemorrhagic fevers
Crimean-Congo hemorrhagic fever virus
Ebola virus
Guanarito virus
Junin virus
Lassa virus
Lujo virus
Machupo virus
Marburg virus
Sabia virus
Yellow fever S S S S S S S S S S 1 1
Zika virus
Zika virus disease, congenital ¶¶ 3 0.44 5 0.17 6 16 30
Zika virus disease, non-congenital 7 0.15 77 0.38 432 0.95 2,516 1.00 492 1,608 5,132
Zika virus infection, congenital ¶¶ 1 0.15 4 0.14 8 32 45
Zika virus infection, non-congenital 27 0.13 218 0.48 240 0.09 120 306 911
[ Export ] [ PDF ] [ Previous Part ] [ Next Part ] [ NNDSS Infectious Annual Tables ] [ NNDSS Infectious Weekly Tables ]
    —: No reported casesU: UnavailableS: Suppressed
  • * Condition had <25 cases reported in the year so data were not broken down by race.
  • † Race data were collected using current Office of Management and Budget (OMB) standards for race/ethnicity data and were mapped to bridged race categories.
  • § Reportable in <25 states.
  • ¶ Total number of reported laboratory-positive dengue cases, including all confirmed cases [by anti-dengue virus (DENV) molecular diagnostic methods or seroconversion of anti-DENV IgM] and all probable cases (by a single, positive anti-DENV IgM).
  • ** Chronic hepatitis B and C data are not included in NNDSS tables but reported case counts are included in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm.
  • †† Includes Escherichia coli O157:H7; shiga toxin-positive, serogroup non-O157; and shiga toxin positive, not serogrouped.
  • §§ Includes syphilis of all stages, including cases where stage of syphilis is not stated.
  • ¶¶ Data reported to ArboNET using the national surveillance case definition for congenital Zika virus disease or infection (CSTE Position Statement 16-ID-01). Additional data reported to the US Zika Pregnancy Registry for outcomes of pregnancies with laboratory evidence of possible Zika virus infection are available at https://www.cdc.gov/zika/reporting/pregnancy-outcomes.html. Cases reported to the US Zika Pregnancy Registry might not meet the national surveillance case definition for congenital Zika virus disease or infection.

TOP